Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols.

[1]  M. Malý,et al.  Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: a preliminary study. , 2023, International journal of pharmaceutics.

[2]  Ting Yu,et al.  Mn-dox metal-organic nanoparticles for cancer therapy and magnetic resonance imaging , 2022, Dyes and Pigments.

[3]  D. Bokov,et al.  Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol , 2021, Frontiers in Bioengineering and Biotechnology.

[4]  S. Michlewska,et al.  CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs , 2021, Cancers.

[5]  P. Ortega,et al.  Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells. , 2021, Dalton transactions.

[6]  R. Gómez,et al.  Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA. , 2021, Journal of inorganic biochemistry.

[7]  N. Esfandiari,et al.  Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy , 2021, Nanoscale Research Letters.

[8]  T. Hianik,et al.  Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation. , 2021, Langmuir.

[9]  S. Das,et al.  Polymeric micelles for anticancer drug delivery. , 2020, Therapeutic delivery.

[10]  P. Ortega,et al.  Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells , 2020, Pharmaceutics.

[11]  P. Ortega,et al.  Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells , 2020, International journal of molecular sciences.

[12]  A. Bajo,et al.  Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer. , 2020, European journal of medicinal chemistry.

[13]  Huile Gao,et al.  Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy. , 2020, Journal of materials chemistry. B.

[14]  J. Majoral,et al.  Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro , 2020, Biomolecules.

[15]  Claudia Sandoval-Yáñez,et al.  Dendrimers: Amazing Platforms for Bioactive Molecule Delivery Systems , 2020, Materials.

[16]  J. Rosenholm,et al.  Nanogels as drug delivery systems: a comprehensive overview. , 2019, Therapeutic delivery.

[17]  Joseph Wang,et al.  Combination of Ruthenium Dendrimers and Acoustically Propelled Gold Nanowires as a Platform for Active Intracellular Drug Delivery Towards Breast Cancer Therapy , 2019 .

[18]  E. Pędziwiatr-Werbicka,et al.  Dendrimers and hyperbranched structures for biomedical applications , 2019, European Polymer Journal.

[19]  P. Ortega,et al.  Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug , 2019, Biomolecules.

[20]  H. Alkreathy,et al.  Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals , 2019, Cancer cell international.

[21]  V. Dzmitruk,et al.  Ruthenium dendrimers against acute promyelocytic leukemia: in vitro studies on HL-60 cells. , 2019, Future medicinal chemistry.

[22]  J. Majoral,et al.  Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer. , 2019, Journal of biomedical materials research. Part A.

[23]  Ionov,et al.  In Vitro Anticancer Properties of Copper Metallodendrimers , 2019, Biomolecules.

[24]  A. Venyaminova,et al.  Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells , 2019, Pharmaceutics.

[25]  M. R. Mozafari,et al.  Probing nanoliposomes using single particle analytical techniques: effect of excipients, solvents, phase transition and zeta potential , 2018, Heliyon.

[26]  T. Etrych,et al.  Polymeric nanogels as drug delivery systems. , 2018, Physiological research.

[27]  M. R. Mozafari,et al.  Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.

[28]  Kun-Sheng Li,et al.  Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  M. Malý,et al.  Ruthenium dendrimers as carriers for anticancer siRNA. , 2018, Journal of inorganic biochemistry.

[30]  G. Caracciolo.  Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona. , 2018, Nanoscale.

[31]  Wahid Khan,et al.  Liposomal Formulations in Clinical Use: An Updated Review , 2017, Pharmaceutics.

[32]  M. Ionov,et al.  Ruthenium metallodendrimers with anticancer potential in an acute promyelocytic leukemia cell line (HL60) , 2017 .

[33]  Sandro Matosevic,et al.  Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape , 2016, Drug delivery.

[34]  R. Gómez,et al.  Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes. , 2016, Dalton transactions.

[35]  J. Majoral,et al.  Effect of dendrimers on selected enzymes--Evaluation of nano carriers. , 2016, International journal of pharmaceutics.

[36]  Jia-Lin Yang,et al.  Nanoparticle-siRNA: A potential cancer therapy? , 2016, Critical reviews in oncology/hematology.

[37]  C. Rauh,et al.  Comparative analysis of bioactive phenolic compounds composition from 26 medicinal plants , 2016, Saudi journal of biological sciences.

[38]  Keerti Jain,et al.  Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers , 2016, Artificial cells, nanomedicine, and biotechnology.

[39]  Sanjeev Banerjee,et al.  Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. , 2015, Colloids and surfaces. B, Biointerfaces.

[40]  Qiang Zhang,et al.  G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[41]  J. Majoral,et al.  Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action. , 2015, International journal of pharmaceutics.

[42]  A. Venyaminova,et al.  Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction. , 2015, International journal of pharmaceutics.

[43]  Heinz-Bernhard Kraatz,et al.  Polymeric micelles as drug delivery vehicles , 2014 .

[44]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[45]  J. Majoral,et al.  Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line , 2013, Cellular & Molecular Biology Letters.

[46]  J. Majoral,et al.  Natural and Synthetic Biomaterials as Composites of Advanced Drug Delivery Nano Systems (ADDNSS). Biomedical Applications , 2013 .

[47]  T. Hianik,et al.  siRNA carriers based on carbosilane dendrimers affect zeta potential and size of phospholipid vesicles. , 2012, Biochimica et biophysica acta.

[48]  Ying Wan,et al.  International Journal of Nanomedicine Dovepress Anticancer Efficacy Enhancement and Attenuation of Side Effects of Doxorubicin with Titanium Dioxide Nanoparticles , 2022 .

[49]  B. R. Steele,et al.  New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. , 2010, Journal of pharmaceutical sciences.

[50]  P. Kesharwani,et al.  Dendrimer toxicity: Let's meet the challenge. , 2010, International journal of pharmaceutics.

[51]  Ling Peng,et al.  PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. , 2006, Chemical communications.

[52]  Barbara Klajnert,et al.  Complexation of HIV derived peptides with carbosilane dendrimers. , 2013, Colloids and surfaces. B, Biointerfaces.